Table 5 Characteristics of participants with and without hepatic steatosis in a subgroup of patients receiving ARB after liver transplantation
Steatosis (+) (n = 11) | Steatosis (-) (n = 24) | P-value | |
|---|---|---|---|
Age (year) | 49.81 ± 11.89 | 50.86 ± 11.66 | 0.809 |
Weight (kg) | 77.09 ± 19.21 | 70.26 ± 14.64 | 0.259 |
BMI (kg/m2) | 26.16 ± 6.20 | 25.36 ± 4.65 | 0.674 |
PTDM, n (%) | 8 (40) | 12 (60) | 0.314 |
Hyperlipidemia, n (%) | 9 (40.9) | 13 (59.1) | 0.149 |
AST (IU/L) | 23 ± 6.43 | 23.19 ± 11.31 | 0.959 |
ALT (IU/L) | 39.18 ± 12.61 | 29.14 ± 24.11 | 0.996 |
ALK. Ph (IU/L) | 209.63 ± 72.09 | 228.23 ± 105.89 | 0.606 |
T. Bilirubin (mg/dL) | 1.04 ± 0.57 | 0.94 ± 0.46 | 0.601 |
D.Bilirubin (mg/dL) | 0.37 ± 0.27 | 0.33 ± 0.25 | 0.712 |
FBS (mg/dL) | 127.90 ± 37.53 | 126.43 ± 62.40 | 0.943 |
TG (mg/dL) | 248 ± 144.83 | 162.09 ± 94.16 | 0.048 |
Cholesterol (mg/dL) | 184.54 ± 48.65 | 191.13 ± 55.51 | 0.740 |
HDL (mg/dL) | 40.09 ± 12.10 | 40.09 ± 12.40 | 0.057 |
LDL (mg/dL) | 93.81 ± 31.54 | 107.81 ± 38.37 | 0.305 |
Rejection, n (%) | 3 (30) | 7 (30) | 0.980 |